9572 completed. 9572 Phase 1, 2792 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 9572 | Completed 9572 |
| Phase 2 | 2792 | Completed 2792 |
Follow Neoplasms: new trials by email Literature Review of Neoplasms trials Research Report on Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Material Balance of [14C]Zorifertinib in Healthy Adult Male Participants in China [14C]Zorifertinib Oral Formulation - EGFR Mutant Advanced Non-small Cell Lung Cancer, Central Nervous System (CNS) Metastases | Phase 1 | Completed | Alpha Biopharma (Jiangsu) Co., Ltd. | 6 | 2026-07-06 | 2026-09-22 |
| A Phase I Study to Evaluate the Safety and Dosimetry of Imaging With 68Ga-OncoACP3 in Prostate Cancer [68Ga]Ga-OncoACP3 - Prostate Cancer | Phase 1 | Completed | Philogen S.p.A. | 20 | 2026-05-27 | 2026-10-27 |
| A Mass Balance Study of DZD8586 in Healthy Male Participants (TAI-SHAN15) DZD8586 - Lymphoma, Non-Hodgkin | Phase 1 | Completed | Dizal Pharmaceuticals | 6 | 2026-03-16 | 2026-05-14 |
| A Study to Assess the Mass Balance of [14C]HRS-8080 in Healthy Chinese Postmenopausal Female Subjects. [14C]HRS-8080 - Breast Cancer | Phase 1 | Completed | Shandong Suncadia Medicine Co., Ltd. | 6 | 2026-01-09 | 2026-06-08 |
| A Trial of Itraconazole Effect on HRS-8080 Pharmacokinetics in Healthy Participants HRS-8080 Tablet, Itraconazole Capsule - Breast Cancer | Phase 1 | Completed | Shandong Suncadia Medicine Co., Ltd. | 16 | 2025-11-26 | 2026-01-14 |
| A Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute Leukemia 14C-bleximenib, bleximenib - Acute Lymphoblastic Leukemia, Acute Leukemias | Phase 1 | Completed | Janssen Research & Development, LLC | 6 | 2025-11-18 | 2026-09-25 |
| Fenretinide Mucoadhesive Patch: Evaluation of Oral Cancer Prevention Efficacy in Adults With Premalignant Oral Lesions. Mucoadhesive fenretinide-releasing system (FMS) - Oral Leukoplakia, Oral Dysplasia | Phase 1 | Completed | Ohio State University Comprehensive Cancer Center | 7 | 2025-10-14 | 2026-09-25 |
| A Study to Learn About How the Study Medicines Called Itraconazole and Probenecid Change How the Body Processes PF-07220060 PF-07220060, Itraconazole, Probenecid - Healthy Adults | Phase 1 | Completed | Pfizer | 25 | 2025-09-22 | 2026-04-03 |
| Investigation of the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Opemalirsen (AZD2373) Opemalirsen (AZD2373) - Renal Impairment | Phase 1 | Completed | AstraZeneca | 35 | 2025-08-18 | 2026-06-26 |
| TGRX-678 Pharmacokinetic Mass Balance [14C]TGRX-678 - Chronic Myeloid Leukemia | Phase 1 | Completed | Shenzhen TargetRx Co., Ltd. | 6 | 2025-07-07 | 2025-09-04 |
| Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and Photodamage Ameluz, Sciton HEROic - Actinic Keratoses, Photodamage | Phase 1 | Completed | Sherrif Ibrahim | 10 | 2025-06-27 | 2026-01-02 |
| A Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Oral HRS-5041 in Healthy Subjects HRS-5041 Tablets, Rifampicin Capsule - Prostate Cancer | Phase 1 | Completed | Jiangsu HengRui Medicine Co., Ltd. | 16 | 2025-06-20 | 2025-09-10 |
| Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs. Radiprodil + co-administered drugs - Tuberous Sclerosis Complex (TSC), Focal Cortical Dysplasia | Phase 1 | Completed | GRIN Therapeutics, Inc. | 18 | 2025-05-20 | 2025-11-18 |
| A Trial of SHR7280 in Healthy Subjects SHR7280 Tablet, SHR7280 Placebo Tablet - Endometriosis, Uterine Fibroids | Phase 1 | Completed | Jiangsu HengRui Medicine Co., Ltd. | 16 | 2025-05-19 | 2025-08-19 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BMS-986489 in Chinese Participants With Relapsed/Refractory Small Cell Lung Cancer BMS-986489 - Small Cell Lung Carcinoma | Phase 1 | Completed | Bristol-Myers Squibb | 10 | 2025-05-07 | 2026-09-24 |
| A Phase 1 Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, Omeprazole, Digoxin, and Rosuvastatin in Healthy Subjects SHR7280 Tablets - Endometriosis, Uterine Fibroids | Phase 1 | Completed | Jiangsu HengRui Medicine Co., Ltd. | 20 | 2025-04-28 | 2025-09-10 |
| A Study of MK-4700 Alone or With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors (MK-4700-001) MK-4700, Pembrolizumab - Malignant Neoplasm | Phase 1 | Completed | Merck Sharp & Dohme LLC | 5 | 2025-04-23 | 2026-03-16 |
| A Phase 1b/2 Multisite Dose-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Metastatic Solid Tumors or Lymphoma WTX-330 - Advanced or Metastatic Solid Tumors, Non-Hodgkin Lymphoma | Phase 1 / Phase 2 | Completed | Werewolf Therapeutics, Inc. | 24 | 2025-04-21 | 2026-10-19 |
| A Study to Evaluate the Safety and Dosimetry of 68Ga-OncoCAIX in Patients With CAIX-positive Cancer [68Ga]Ga-OncoCAIX - Clear Cell Renal Cell Carcinoma (ccRCC) | Phase 1 | Completed | Philogen S.p.A. | 20 | 2025-04-16 | 2026-01-13 |
| Effect of NAE on Polycystic Ovarian Syndrome (PCOS) Herbal Formulation, Metformin XR, Metformin 750 mg and herbal formulation 500 mg - Polycystic Ovarian Syndrome (PCOS), Infertility | Phase 1 | Completed | Jinnah Sindh Medical University | 116 | 2025-04-10 | 2026-06-22 |
Showing 20 of 9572. Sign in to see all of them.
Breast Neoplasms (966) · Carcinoma, Non-Small-Cell Lung (781) · Leukemia, Myeloid, Acute (634) · Lymphoma (582) · Melanoma (579) · Neoplasm Metastasis (565) · Multiple Myeloma (550) · Prostatic Neoplasms (550) · Colorectal Neoplasms (515) · Lymphoma, Non-Hodgkin (493) · Pancreatic Neoplasms (469) · Ovarian Neoplasms (461) · Leukemia, Lymphocytic, Chronic, B-Cell (444) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (434)
Neoplasms by Site (5534) · Neoplasms by Histologic Type (5144) · Hemic and Lymphatic Diseases (2675) · Immune System Diseases (2066) · Immunoproliferative Disorders (2009) · Neoplasms, Glandular and Epithelial (2007) · Lymphoproliferative Disorders (1995) · Hematologic Diseases (1893) · Pathological Conditions, Signs and Symptoms (1694) · Skin and Connective Tissue Diseases (1646) · Lymphatic Diseases (1640) · Skin Diseases (1629) · Urogenital Diseases (1616) · Digestive System Diseases (1601)
Cyclophosphamide (346) · Paclitaxel (335) · Gemcitabine (326) · Radiotherapy (325) · Carboplatin (308) · Cisplatin (305) · pembrolizumab (274) · Nivolumab (213) · Docetaxel (207) · Dexamethasone (203) · Rituximab (189) · Bevacizumab (182) · Cytarabine (182) · Irinotecan (172) · Capecitabine (167)
National Cancer Institute (NCI) (622) · M.D. Anderson Cancer Center (275) · Memorial Sloan Kettering Cancer Center (239) · Novartis Pharmaceuticals (163) · AstraZeneca (129) · Hoffmann-La Roche (123) · Eli Lilly and Company (122) · GlaxoSmithKline (115) · Bristol-Myers Squibb (106) · Pfizer (105) · Bayer (97) · Merck Sharp & Dohme LLC (97) · Boehringer Ingelheim (94) · Dana-Farber Cancer Institute (91) · Mayo Clinic (89)
United States (6626) · Canada (639) · France (634) · Spain (590) · United Kingdom (585) · China (513) · Germany (485) · Australia (402) · Japan (378) · Netherlands (360) · Italy (345) · South Korea (341) · Belgium (287) · Taiwan (165) · Switzerland (157)
PMID 34515338, PMID 31401903, PMID 19238148, PMID 36897458, PMID 22473314, PMID 32499241, PMID 31355467, PMID 32770353, PMID 33465252, PMID 33883258, PMID 34398557, PMID 37022569, PMID 38172595, PMID 39462179, PMID 39863139, PMID 24919854, PMID 25475068, PMID 26943915, PMID 27240885, PMID 28803351, PMID 31395089, PMID 32078016, PMID 32705923, PMID 32747469, PMID 34311780, PMID 34687939, PMID 34780125, PMID 35293148, PMID 36383907, PMID 37486616, PMID 37981564, PMID 39368878, PMID 39813680, PMID 40132910, PMID 15117425, PMID 15944250, PMID 16157940, PMID 16546506, PMID 16758122, PMID 16775234, PMID 16783576, PMID 17273752, PMID 17906897, PMID 18245541, PMID 18392824, PMID 18536917, PMID 18726994, PMID 19192962, PMID 19351776, PMID 19451441
2015 (93), 2016 (87), 2017 (69), 2014 (64), 2009 (57), 2018 (57), P30CA016672 (54), 2019 (47), P30CA015704 (44), P30CA015083 (42), 2008 (39), P30CA033572 (37), P30CA006973 (35), 2023 (33), P30CA008748 (29)